Rheumatology (Oxford, England)
Cure8 research brief
Why This Matters
People with IBD and other IMIDs often need ongoing medication during pregnancy.
This study provides population-based data suggesting most conditions did not have higher spontaneous loss and that common IBD medications studied were not linked to increased spontaneous loss; however, a borderline rise in congenital malformations for IBD warrants careful interpretation and further study.
Who Should Pay Attention
Pregnant patients with IBD or other immune-mediated inflammatory diseases, obstetricians and gastroenterologists, IBD clinicians, and researchers studying pregnancy outcomes and medication safety.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The study used primary-care linked data to identify pregnancies and prescriptions, and evaluated commonly used disease-modifying drugs in pregnancy. Azathioprine, mesalazine and sulfasalazine were not associated with increased spontaneous loss in this analysis.
The IBD finding for MCMs was borderline and sensitivity analyses and confounding are noted by the authors. The abstract provides a high-level summary; it does not give detailed absolute risks, subgroup numbers, or specific timing/doses for medications. Decisions about treatment in pregnancy should remain individualized and discussed with clinicians.
Keep In Mind
Structured-content depth is an abstract from a peer-reviewed journal; this brief is grounded in that abstract and does not reflect a review of full article details. The authors note potential residual confounding and the abstract lacks detailed medication dosing, timing, and absolute risk estimates. Individual treatment decisions require clinical consultation.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationRheumatology (Oxford, England)
AuthorsRachel Charlton, William Tillett, Neil McHugh +1 more
InstitutionDepartment of Life Sciences, University of Bath, Bath, United Kingdom.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 7, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Predictors of hypertensive disorders of pregnancy among patients with inflammatory bowel disease
People with IBD may face higher-than-expected rates of hypertensive disorders in pregnancy; identifying predictors could help target monitoring and preventive strategies. The study suggests prior HDP and gestational...
IBD and Pregnancy Risks: Few Women Discuss Contraception With Their IBD Specialist
Pregnancy planning and contraception are important for people with IBD because active disease at conception is linked to worse pregnancy outcomes. The article shows many women with IBD are unsure about how contraception...
Inflammatory bowel disease and risk of perineal injury in primiparous vaginal births: a retrospective cohort study
This helps people with IBD and their care teams make delivery plans: if perianal disease is not active, having IBD alone was not linked to higher perineal injury risk in first-time vaginal births in this study.